These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 24746707
21. Relapse of IgA lambda multiple myeloma presenting as obstructive jaundice and abdominal pain. Annibali O, Marchesi F, Petrucci MT, Tirindelli MC, Avvisati G. Onkologie; 2009 Mar; 32(3):119-21. PubMed ID: 19295251 [Abstract] [Full Text] [Related]
22. Refractory multiple myeloma treated with homoharringtonine: report of two cases. Yang X, Yang C, Shao K, Ye X, Meng H, Zhou Y, Qian W. Ann Hematol; 2007 Dec; 86(12):919-21. PubMed ID: 17641891 [No Abstract] [Full Text] [Related]
23. [Relapsed/refractory multiple myeloma with CD138 shedding and formation of extramedullary disease in the common bile duct region presenting as obstructive jaundice]. Yokoyama A, Hosoda T, Shiraishi J, Yamamoto R, Yoneda M, Ohashi K, Okabe T, Kagoo T, Boku S, Ueno H, Yano T. Rinsho Ketsueki; 2015 Aug; 56(8):1089-95. PubMed ID: 26345572 [Abstract] [Full Text] [Related]
31. Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma. Zemanova M, Scudla V, Adam Z, Gregora E, Pour L, Minarik J, Pavlicek P, Pika T, Bacovsky J. Neoplasma; 2008 Jul; 55(4):345-9. PubMed ID: 18505347 [Abstract] [Full Text] [Related]
32. Combination chemotherapy with cyclophosphamide, thalidomide and dexamethasone for patients with refractory, newly diagnosed or relapsed myeloma. Sidra G, Williams CD, Russell NH, Zaman S, Myers B, Byrne JL. Haematologica; 2006 Jun; 91(6):862-3. PubMed ID: 16769594 [Abstract] [Full Text] [Related]
33. An unusual common bile duct stricture after cholecystectomy. Born P, Käser F, Rösch T. Endoscopy; 2002 Aug; 34(8):681. PubMed ID: 12173099 [No Abstract] [Full Text] [Related]
34. Bortezomib-cyclophosphamide-dexamethasone (VCD) versus bortezomib-thalidomide-dexamethasone (VTD) -based regimens as induction therapies in newly diagnosed transplant eligible patients with multiple myeloma: a meta-analysis. Leiba M, Kedmi M, Duek A, Freidman T, Weiss M, Leiba R, Nagler A, Avigdor A. Br J Haematol; 2014 Sep; 166(5):702-10. PubMed ID: 24861981 [Abstract] [Full Text] [Related]
35. [Endoscopic prosthetic treatment in stenosis of the choledochus caused by malignant disease]. Pedersen FM. Ugeskr Laeger; 1993 Jan 11; 155(2):83-5. PubMed ID: 8421865 [Abstract] [Full Text] [Related]
36. [Possibilities and limits of ultrasound tomography in extrahepatic cholestasis. 2: Diagnosis of occlusion etiology]. Wermke W. Z Arztl Fortbild (Jena); 1985 Jan 11; 79(16):675-80. PubMed ID: 3904235 [No Abstract] [Full Text] [Related]
37. [Treatment of transplant-eligible symptomatic multiple myeloma]. Nakaseko C. Rinsho Ketsueki; 2014 Oct 11; 55(10):2016-26. PubMed ID: 25297767 [No Abstract] [Full Text] [Related]
38. Malignant biliary obstruction complicated by ascites: transjugular insertion of an expandable metallic endoprosthesis. Ring EJ, Gordon RL, LaBerge JM, Shapiro HA. Radiology; 1991 Aug 11; 180(2):579-81. PubMed ID: 2068334 [Abstract] [Full Text] [Related]
39. Rapid response of plasmacytomas to lenalidomide plus low-dose dexamethasone therapy in a patient with relapsed multiple myeloma. Fukushima T, Nakamura T, Iwao H, Umehara H. Am J Hematol; 2011 Oct 11; 86(10):893. PubMed ID: 21812018 [No Abstract] [Full Text] [Related]